Study Shows Continuous Glucose Monitoring Benefits Type 2 Diabetes Patients Not Using Insulin

The Dexcom CONNECT Study, published in The New England Journal of Medicine, indicates that real-time continuous glucose monitoring (CGM) significantly lowers A1C and improves glucose control for adults with Type 2 diabetes not on insulin. This randomized trial suggests CGM could be beneficial earlier in Type 2 diabetes management, including for those over 65 and those taking GLP-1 medications.